# Long COVID-19 Cutaneous Signatures: An ARPA Funded Research Project

> **NCT07005947** · — · ACTIVE_NOT_RECRUITING · sponsor: **CND Life Sciences** · enrollment: 300 (estimated)

## Conditions studied

- Long COVID-19
- Acute COVID-19
- Postural Orthostatic Tachycardia Syndrome (POTS)
- Diabetic Neuropathy

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT07005947
- **Lead sponsor:** CND Life Sciences
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2023-11-30
- **Primary completion:** 2026-02-28
- **Final completion:** 2026-04-16
- **Target enrollment:** 300 (ESTIMATED)
- **Last updated:** 2026-02-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07005947

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07005947, "Long COVID-19 Cutaneous Signatures: An ARPA Funded Research Project". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT07005947. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*